This brand name is authorized in Austria, Brazil, Cyprus, Germany, Ecuador, Estonia, Spain, France, Hong Kong, Japan, Lithuania, Malta, Netherlands, New Zealand, Poland, Romania, Singapore, Tunisia, Turkey, South Africa
The drug ZYRTEC contains one active pharmaceutical ingredient (API):
1
Cetirizine
UNII 64O047KTOA - CETIRIZINE HYDROCHLORIDE
|
Cetirizine, a human metabolite of hydroxyzine, is a potent and selective antagonist of peripheral H1-receptors. In vitro receptor binding studies have shown no measurable affinity for other than Η1-receptors. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
ZYRTEC Film-coated tablet / Oral drops / Oral solution | Health Sciences Authority (SG) | MPI, Generic |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
R06AE07 | Cetirizine | R Respiratory system → R06 Antihistamines for systemic use → R06A Antihistamines for systemic use → R06AE Piperazine derivatives |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 510609601112312, 510609603131314 |
Country: DE | Bundesinstitut für Arzneimittel und Medizinprodukte | Identifier(s): 00243748, 00257940, 01433215, 01433221, 01433238, 01467852, 03738203, 04394326, 04394332, 04811126, 04811149, 04811155, 04967029, 04967041, 07736394 |
Country: EC | Agencia Nacional de Regulación, Control y Vigilancia Sanitaria | Identifier(s): 30024-11-11, 30047-11-11, 30058-12-11 |
Country: EE | Ravimiamet | Identifier(s): 1022858, 1022869, 1026526, 1077825, 1077836, 1077847, 1525014, 1525025, 1525047, 1525058, 1525115, 1525126, 1525171, 1525182, 1525193, 1525205, 1525216, 1525227, 1525238, 1525249, 1525250, 1525261, 1525272, 1525283, 1728637, 1731563, 1731574, 1731585, 1826580, 1828537, 1829897, 1829909 |
Country: ES | Centro de información online de medicamentos de la AEMPS | Identifier(s): 58481, 60279, 60280, R-1846, R-1846IP, R1846 |
Country: FR | Base de données publique des médicaments | Identifier(s): 64949486, 65016707 |
Country: HK | Department of Health Drug Office | Identifier(s): 33733, 40728 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 4490020F1020, 4490020F2027, 4490020R1027 |
Country: LT | Valstybinė vaistų kontrolės tarnyba | Identifier(s): 1003218, 1003219, 1010903, 1010904, 1065605, 1066078, 1069324, 1082128, 1084154, 1085498, 1085687, 1086334, 1088373, 1091412, 1091413 |
Country: MT | Medicines Authority | Identifier(s): MA030/00901, MA030/00902, PI908/01901A |
Country: NL | Z-Index G-Standaard, PRK | Identifier(s): 26298, 38601 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 6329, 6330 |
Country: PL | Rejestru Produktów Leczniczych | Identifier(s): 100001901, 100074834, 100074857, 100131970, 100412515, 100454164 |
Country: RO | Agenția Națională a Medicamentului și a Dispozitivelor Medicale | Identifier(s): W59369001, W59369002, W59369003 |
Country: SG | Health Sciences Authority | Identifier(s): 03022P, 08945P, 10796P, 14890P, 15437P |
Country: TN | Direction de la Pharmacie et du Médicament | Identifier(s): 9073241 |
Country: TR | İlaç ve Tıbbi Cihaz Kurumu | Identifier(s): 8699624090041, 8699624570048, 8699624590015 |
Country: ZA | Health Products Regulatory Authority | Identifier(s): 28/5.7.1/0477, W/5.7.1/148 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.